XML 76 R57.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of weighted average assumptions used to estimate the grant date fair value of options granted
The fair value of each stock option or LTIP Unit granted is estimated on the date of grant using the Black-Scholes option pricing model based on historical information with the following weighted average assumptions for grants during the year ended December 31, 2024 (there were no options granted during the years ended December 31, 2023 and 2022).
202420232022
Dividend yield5.5 %N/AN/A
Expected life7.5 yearsN/AN/A
Risk-free interest rate4.45 %N/AN/A
Expected stock price volatility45.0 %N/AN/A
Summary of the status of stock options and changes during the period
A summary of the status of the Company's stock options as of December 31, 2024, 2023, and 2022 and changes during the years ended December 31, 2024, 2023, and 2022 are as follows:
Year Ended December 31,
202420232022
Options OutstandingWeighted Average
Exercise Price		Options OutstandingWeighted Average
Exercise Price		Options
Outstanding		Weighted
Average
Exercise
Price
Balance at beginning of year115,980 $103.52 313,480 $97.59 394,089 $100.56 
Granted217,917 68.07 — — — — 
Lapsed or canceled— — (197,500)84.14 (80,609)112.14 
Balance at end of year333,897 $81.63 115,980 $103.52 313,480 $97.59 
Options exercisable at end of year115,980 $103.52 115,980 $103.52 313,480 $97.59 
Schedule of other share-based compensation, activity
A summary of the Company's restricted stock as of December 31, 2024, 2023, and 2022 and changes during the years ended December 31, 2024, 2023, and 2022 are as follows:
Year Ended December 31,
202420232022
Balance at beginning of year4,089,174 3,758,174 3,459,363 
Granted371,285 337,350 314,995 
Canceled(10,750)(6,350)(16,184)
Balance at end of year4,449,709 4,089,174 3,758,174 
Vested during the year143,453 147,915 118,255 
Compensation expense recorded$10,939,602 $7,766,055 $10,133,905 
Total fair value of restricted stock granted during the year$24,676,422 $15,789,540 $16,804,931